Jianli Wu

Prof. Jianli Wu

Huazhong University of Science and Technology

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in Life Sciences
Verified
Journal Article
Closed access
WLWei Li
Wei Li
NYNan Yu
Nan Yu
LFLei Fan
Lei Fan
SCSu-Hua Chen
Su-Hua Chen
JWJianli Wu
Jianli Wu

18 December 2025 in Journal of Molecular Medicine
Verified
Journal Article
Open access
XZXuan Zhou
Xuan Zhou
HZHuiting Zhang
Huiting Zhang
LWLijie Wei
Lijie Wei
ZWZizhuo Wang
Zizhuo Wang
SZShenglan Zhu
Shenglan Zhu
JWJianli Wu
Jianli Wu
Gestational diabetes mellitus (GDM) has become a significant concern in the domain of women's health. The pathophysiology of GDM is complicated and not entirely understood. As a functional interface of the maternal and fetal metabolisms, it is evident that the placenta exerts an effect on the development of GDM. The placenta not only involves itself in insulin resistance via the production of hormones, but also serves as an organ abundant in mitochondria and exhibits intense metabolic activities, rendering it particularly vulnerable to the adverse effects of oxidative stress. In the high-glucose environment, excessive oxidative damage leads to mitochondrial dysfunction and further induces ferroptosis by facilitating lipid peroxidation. The objective of this review is to predominantly assess recent research, published within the last five years, that investigates the roles of placental oxidative stress, mitochondrial dysfunction, and ferroptosis as pathological mechanisms influencing the development of GDM. Understanding these pathological changes may help to better explore novel therapeutic strategies for GDM.


11 June 2026 in Diabetologia
Verified
Journal Article
Open access
YFYilin Fu
Yilin Fu
NLNary Long
Nary Long
PSPhannaroat Sourn
Phannaroat Sourn
MZMengqi Zhang
Mengqi Zhang
WTWeidong Tan
Weidong Tan
WDWencheng Ding
Wencheng Ding
Aims/hypothesis: We aimed to characterise alterations in the late-pregnancy vaginal microbiota in women with gestational diabetes mellitus (GDM), and to examine their associations with maternal glycaemic status and fetal growth. Methods: In this observational case–control study, women with newly diagnosed, diet-managed GDM ( n =60) and healthy pregnant control participants ( n =119) were recruited at a single tertiary centre. Vaginal swabs were collected in the third trimester and analysed by full-length 16S rRNA gene sequencing. Associations between vaginal microbiota composition, maternal glycaemic measures, and fetal birthweight percentile (FBW%ile) were evaluated. Results: The overall vaginal microbial composition differed between groups despite similar alpha diversity. Beta diversity analyses showed significant separation between the women with GDM and the control group ( R =0.068, p =0.011 by ANOSIM). Lactobacillus- dominated communities were less frequent in women with GDM than in control participants (73.3% vs 86.6%, p =0.029), with reduced Lactobacillus abundance (79.8% vs 87.4%, nominal p =0.020) and increased Gardnerella abundance (9.7% vs 1.4%, nominal p =0.011). Within the GDM group, Gardnerella abundance correlated positively with fasting glucose levels ( r =0.3617, nominal p =0.007) and inversely with FBW%ile ( r =−0.2774, nominal p =0.032). Stratification by FBW%ile (<50% vs ≥50%) showed a higher proportion of non- Lactobacillus- dominated communities (44.4% vs 12.1%, p =0.001) and higher Gardnerella abundance (15.0% vs 3.2%, nominal p =0.020) in the low FBW%ile subgroup. Associations with Gardnerella were attenuated in sensitivity analyses that excluded samples with extreme Gardnerella abundance. Conclusions/interpretation: Late-pregnancy GDM was associated with modest shifts in vaginal microbial structure, characterised by reduced Lactobacillus dominance and relative enrichment of Gardnerella . Exploratory analyses of associations of Gardnerella with maternal fasting glucose levels and fetal growth suggest that variation in the vaginal microbial environment may contribute to metabolic and fetal growth heterogeneity in women with GDM.